TTField therapy with chemotherapy improved median overall and pain-free survival in pancreatic cancer, according to new data ...

Novocure (Nasdaq:NVCR) today announced positive results from the Phase 3 PANOVA-3 trial of its tumor-treating fields (TTFields) therapy.